We, therefore, aimed to explore the association of pre‐diagnostic circulating concentrations of LCN2 with incident CRC and its subsites, by sex and adiposity status, in a nested case–control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. This evidence concerns the gene LCN2 and colorectal carcinoma.